Impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life of people with ME/CFS and their partners and family members: an online cross-sectional survey
ObjectivesThe aim of this study was to assess the impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life (QoL) of people with ME/CFS and their relative or partner (family member).DesignA patient-partner, multinational, subject-initiated, cross-sectional online s...
Saved in:
| Published in | BMJ open Vol. 12; no. 5; p. e058128 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
British Medical Journal Publishing Group
02.05.2022
BMJ Publishing Group LTD BMJ Publishing Group |
| Series | Original research |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2044-6055 2044-6055 |
| DOI | 10.1136/bmjopen-2021-058128 |
Cover
| Abstract | ObjectivesThe aim of this study was to assess the impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life (QoL) of people with ME/CFS and their relative or partner (family member).DesignA patient-partner, multinational, subject-initiated, cross-sectional online survey.SettingInternational survey using ME/CFS charities, support groups and social media.ParticipantsParticipants were self-selected with recruitment via social media. Inclusion criteria were aged 18 years or over and reported diagnosis of ME/CFS by health professional. 1418 people with ME/CFS and their 1418 family members from 30 countries participated in the survey. Participants with ME/CFS had a mean age of 45.8 years (range 18–81) and were predominantly women (1214 (85.6%) of 1418). Family members had a mean age of 51.9 years (range 18–87) and were predominantly men (women: 504 (35.5%) of 1418). 991 (70%) family members were partners of the people with ME/CFS.InterventionsEuroQoL-5 Dimension (EQ-5D-3L), completed by people with ME/CFS, and Family Reported Outcome Measure (FROM-16) questionnaire, completed by family members.ResultsThe mean overall health status on a Visual Analogue Scale for people with ME/CFS was 33.8 (0=worst, 100=best). People with ME/CFS were most affected by ability to perform usual activities, pain, mobility, self-care and least impacted by anxiety. For family members, the overall mean FROM-16 score was 17.9 (0=no impact, 32=worst impact), demonstrating a major impact on QoL. Impact on QoL was significantly correlated between the person with ME/CFS and their family member (p<0.0001). Family members were most impacted emotionally by worry, frustration and sadness and personally by family activities, holidays, sex life and finances.ConclusionsTo the best of our knowledge, this is the largest study on the impact of the QoL of persons with ME/CFS and their family members. While open participation surveys are limited by selection bias, this research has revealed a significant worldwide burden of ME/CFS on the QoL of people with ME/CFS and their family members. |
|---|---|
| AbstractList | ObjectivesThe aim of this study was to assess the impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life (QoL) of people with ME/CFS and their relative or partner (family member).DesignA patient-partner, multinational, subject-initiated, cross-sectional online survey.SettingInternational survey using ME/CFS charities, support groups and social media.ParticipantsParticipants were self-selected with recruitment via social media. Inclusion criteria were aged 18 years or over and reported diagnosis of ME/CFS by health professional. 1418 people with ME/CFS and their 1418 family members from 30 countries participated in the survey. Participants with ME/CFS had a mean age of 45.8 years (range 18–81) and were predominantly women (1214 (85.6%) of 1418). Family members had a mean age of 51.9 years (range 18–87) and were predominantly men (women: 504 (35.5%) of 1418). 991 (70%) family members were partners of the people with ME/CFS.InterventionsEuroQoL-5 Dimension (EQ-5D-3L), completed by people with ME/CFS, and Family Reported Outcome Measure (FROM-16) questionnaire, completed by family members.ResultsThe mean overall health status on a Visual Analogue Scale for people with ME/CFS was 33.8 (0=worst, 100=best). People with ME/CFS were most affected by ability to perform usual activities, pain, mobility, self-care and least impacted by anxiety. For family members, the overall mean FROM-16 score was 17.9 (0=no impact, 32=worst impact), demonstrating a major impact on QoL. Impact on QoL was significantly correlated between the person with ME/CFS and their family member (p<0.0001). Family members were most impacted emotionally by worry, frustration and sadness and personally by family activities, holidays, sex life and finances.ConclusionsTo the best of our knowledge, this is the largest study on the impact of the QoL of persons with ME/CFS and their family members. While open participation surveys are limited by selection bias, this research has revealed a significant worldwide burden of ME/CFS on the QoL of people with ME/CFS and their family members. The aim of this study was to assess the impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life (QoL) of people with ME/CFS and their relative or partner (family member).OBJECTIVESThe aim of this study was to assess the impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life (QoL) of people with ME/CFS and their relative or partner (family member).A patient-partner, multinational, subject-initiated, cross-sectional online survey.DESIGNA patient-partner, multinational, subject-initiated, cross-sectional online survey.International survey using ME/CFS charities, support groups and social media.SETTINGInternational survey using ME/CFS charities, support groups and social media.Participants were self-selected with recruitment via social media. Inclusion criteria were aged 18 years or over and reported diagnosis of ME/CFS by health professional. 1418 people with ME/CFS and their 1418 family members from 30 countries participated in the survey. Participants with ME/CFS had a mean age of 45.8 years (range 18-81) and were predominantly women (1214 (85.6%) of 1418). Family members had a mean age of 51.9 years (range 18-87) and were predominantly men (women: 504 (35.5%) of 1418). 991 (70%) family members were partners of the people with ME/CFS.PARTICIPANTSParticipants were self-selected with recruitment via social media. Inclusion criteria were aged 18 years or over and reported diagnosis of ME/CFS by health professional. 1418 people with ME/CFS and their 1418 family members from 30 countries participated in the survey. Participants with ME/CFS had a mean age of 45.8 years (range 18-81) and were predominantly women (1214 (85.6%) of 1418). Family members had a mean age of 51.9 years (range 18-87) and were predominantly men (women: 504 (35.5%) of 1418). 991 (70%) family members were partners of the people with ME/CFS.EuroQoL-5 Dimension (EQ-5D-3L), completed by people with ME/CFS, and Family Reported Outcome Measure (FROM-16) questionnaire, completed by family members.INTERVENTIONSEuroQoL-5 Dimension (EQ-5D-3L), completed by people with ME/CFS, and Family Reported Outcome Measure (FROM-16) questionnaire, completed by family members.The mean overall health status on a Visual Analogue Scale for people with ME/CFS was 33.8 (0=worst, 100=best). People with ME/CFS were most affected by ability to perform usual activities, pain, mobility, self-care and least impacted by anxiety. For family members, the overall mean FROM-16 score was 17.9 (0=no impact, 32=worst impact), demonstrating a major impact on QoL. Impact on QoL was significantly correlated between the person with ME/CFS and their family member (p<0.0001). Family members were most impacted emotionally by worry, frustration and sadness and personally by family activities, holidays, sex life and finances.RESULTSThe mean overall health status on a Visual Analogue Scale for people with ME/CFS was 33.8 (0=worst, 100=best). People with ME/CFS were most affected by ability to perform usual activities, pain, mobility, self-care and least impacted by anxiety. For family members, the overall mean FROM-16 score was 17.9 (0=no impact, 32=worst impact), demonstrating a major impact on QoL. Impact on QoL was significantly correlated between the person with ME/CFS and their family member (p<0.0001). Family members were most impacted emotionally by worry, frustration and sadness and personally by family activities, holidays, sex life and finances.To the best of our knowledge, this is the largest study on the impact of the QoL of persons with ME/CFS and their family members. While open participation surveys are limited by selection bias, this research has revealed a significant worldwide burden of ME/CFS on the QoL of people with ME/CFS and their family members.CONCLUSIONSTo the best of our knowledge, this is the largest study on the impact of the QoL of persons with ME/CFS and their family members. While open participation surveys are limited by selection bias, this research has revealed a significant worldwide burden of ME/CFS on the QoL of people with ME/CFS and their family members. The aim of this study was to assess the impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life (QoL) of people with ME/CFS and their relative or partner (family member). A patient-partner, multinational, subject-initiated, cross-sectional online survey. International survey using ME/CFS charities, support groups and social media. Participants were self-selected with recruitment via social media. Inclusion criteria were aged 18 years or over and reported diagnosis of ME/CFS by health professional. 1418 people with ME/CFS and their 1418 family members from 30 countries participated in the survey. Participants with ME/CFS had a mean age of 45.8 years (range 18-81) and were predominantly women (1214 (85.6%) of 1418). Family members had a mean age of 51.9 years (range 18-87) and were predominantly men (women: 504 (35.5%) of 1418). 991 (70%) family members were partners of the people with ME/CFS. EuroQoL-5 Dimension (EQ-5D-3L), completed by people with ME/CFS, and Family Reported Outcome Measure (FROM-16) questionnaire, completed by family members. The mean overall health status on a Visual Analogue Scale for people with ME/CFS was 33.8 (0=worst, 100=best). People with ME/CFS were most affected by ability to perform usual activities, pain, mobility, self-care and least impacted by anxiety. For family members, the overall mean FROM-16 score was 17.9 (0=no impact, 32=worst impact), demonstrating a major impact on QoL. Impact on QoL was significantly correlated between the person with ME/CFS and their family member (p<0.0001). Family members were most impacted emotionally by worry, frustration and sadness and personally by family activities, holidays, sex life and finances. To the best of our knowledge, this is the largest study on the impact of the QoL of persons with ME/CFS and their family members. While open participation surveys are limited by selection bias, this research has revealed a significant worldwide burden of ME/CFS on the QoL of people with ME/CFS and their family members. Objectives The aim of this study was to assess the impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life (QoL) of people with ME/CFS and their relative or partner (family member).Design A patient-partner, multinational, subject-initiated, cross-sectional online survey.Setting International survey using ME/CFS charities, support groups and social media.Participants Participants were self-selected with recruitment via social media. Inclusion criteria were aged 18 years or over and reported diagnosis of ME/CFS by health professional. 1418 people with ME/CFS and their 1418 family members from 30 countries participated in the survey. Participants with ME/CFS had a mean age of 45.8 years (range 18–81) and were predominantly women (1214 (85.6%) of 1418). Family members had a mean age of 51.9 years (range 18–87) and were predominantly men (women: 504 (35.5%) of 1418). 991 (70%) family members were partners of the people with ME/CFS.Interventions EuroQoL-5 Dimension (EQ-5D-3L), completed by people with ME/CFS, and Family Reported Outcome Measure (FROM-16) questionnaire, completed by family members.Results The mean overall health status on a Visual Analogue Scale for people with ME/CFS was 33.8 (0=worst, 100=best). People with ME/CFS were most affected by ability to perform usual activities, pain, mobility, self-care and least impacted by anxiety. For family members, the overall mean FROM-16 score was 17.9 (0=no impact, 32=worst impact), demonstrating a major impact on QoL. Impact on QoL was significantly correlated between the person with ME/CFS and their family member (p<0.0001). Family members were most impacted emotionally by worry, frustration and sadness and personally by family activities, holidays, sex life and finances.Conclusions To the best of our knowledge, this is the largest study on the impact of the QoL of persons with ME/CFS and their family members. While open participation surveys are limited by selection bias, this research has revealed a significant worldwide burden of ME/CFS on the QoL of people with ME/CFS and their family members. |
| Author | Singh, Ravinder Muirhead, Nina Ephgrave, Rachel Vyas, Jui Finlay, Andrew Y |
| AuthorAffiliation | 3 Division of Infection and Immunity, School of Medicine , Cardiff University , Cardiff , UK 2 Dermatology , Buckinghamshire Healthcare NHS Trust , Amersham , UK 4 Patient Research Partner , Gloucestershire , UK 1 Centre for Medical Education, School of Medicine , Cardiff University , Cardiff , UK |
| AuthorAffiliation_xml | – name: 1 Centre for Medical Education, School of Medicine , Cardiff University , Cardiff , UK – name: 4 Patient Research Partner , Gloucestershire , UK – name: 2 Dermatology , Buckinghamshire Healthcare NHS Trust , Amersham , UK – name: 3 Division of Infection and Immunity, School of Medicine , Cardiff University , Cardiff , UK |
| Author_xml | – sequence: 1 givenname: Jui orcidid: 0000-0003-2839-2651 surname: Vyas fullname: Vyas, Jui email: vyasjj@cardiff.ac.uk organization: Centre for Medical Education, School of Medicine, Cardiff University, Cardiff, UK – sequence: 2 givenname: Nina surname: Muirhead fullname: Muirhead, Nina organization: Dermatology, Buckinghamshire Healthcare NHS Trust, Amersham, UK – sequence: 3 givenname: Ravinder surname: Singh fullname: Singh, Ravinder organization: Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK – sequence: 4 givenname: Rachel surname: Ephgrave fullname: Ephgrave, Rachel organization: Patient Research Partner, Gloucestershire, UK – sequence: 5 givenname: Andrew Y orcidid: 0000-0003-2143-1646 surname: Finlay fullname: Finlay, Andrew Y organization: Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35501074$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9ksFu1DAQhiNUREvpEyAhS1zKIazj2InDoRKqWqhUxAE4W44z3vXKsVM7Kcqr8XQ4uy20PTQXRzP__2nG_l9nB847yLK3Bf5YFGW1avutH8DlBJMix4wXhL_IjgimNK8wYwcP_g-zkxi3OH2UNYyRV9lhyRgucE2Psj9X_SDViLxG_Szt2igETsGwkdb3M1gzmrhSm-Bd6mg5mvUEKM6uC74HdPrtYnV--eMD8g6NG0A3k0yOeaFZo2E5B_CDBfTbjBu0VyPpukVtAhpkGB2EuCtp2Rs7ox76NpU-pVrCWuMAqeBjzCOo0XgnLYpTuIX5TfZSSxvh5O48zn5dXvw8_5pff_9ydf75Om8pozxnEpOm4hWHrpK6LTWrmqpoAZSqG6ZIy9tal7zStJCkYhQ4wU1XKdJhhsu6Lo-zqz2383IrhmB6GWbhpRG7gg9rkdYwyoIoNeZdwWknFaM1U1JpSmvdKkJJXbRtYp3tWcPU9tApcGOQ9hH0cceZjVj7W9HginBCE-D0DhD8zQRxFL2JCqyVDvwURdqgIYQ3ZZOk759It34K6f4WVVVRzku6bPfu4UT_RrmPSBI0e8HuFQJoocwol5dIAxorCiyWRIq7RIolkWKfyOQtn3jv8c-7VntXav6f-TnHX99m96Q |
| CitedBy_id | crossref_primary_10_1097_WAD_0000000000000647 crossref_primary_10_1007_s11553_023_01098_5 crossref_primary_10_3390_medicina60081215 crossref_primary_10_1007_s11136_023_03498_8 crossref_primary_10_1007_s11553_023_01070_3 crossref_primary_10_3390_jcm13113168 crossref_primary_10_3389_fimmu_2024_1352744 crossref_primary_10_1111_dom_16058 crossref_primary_10_1186_s12967_024_05410_5 crossref_primary_10_1055_a_2212_2344 crossref_primary_10_1186_s40478_023_01662_2 crossref_primary_10_7759_cureus_43424 crossref_primary_10_3310_nihropenres_13421_4 crossref_primary_10_3310_nihropenres_13421_3 crossref_primary_10_1097_MS9_0000000000000929 crossref_primary_10_3310_nihropenres_13421_2 crossref_primary_10_3310_nihropenres_13421_1 crossref_primary_10_3389_fimmu_2024_1386607 crossref_primary_10_1055_a_2197_6479 crossref_primary_10_3399_BJGPO_2024_0079 crossref_primary_10_1080_21641846_2024_2303887 crossref_primary_10_1016_j_ijbiomac_2024_133968 crossref_primary_10_1111_ejh_14206 crossref_primary_10_1080_27707571_2024_2359958 crossref_primary_10_1007_s15006_023_2894_z crossref_primary_10_1007_s11553_024_01170_8 crossref_primary_10_1007_s11553_025_01197_5 crossref_primary_10_1055_a_2323_9507 crossref_primary_10_1007_s11553_024_01153_9 crossref_primary_10_1016_j_heliyon_2024_e27031 crossref_primary_10_1136_bmj_o1691 crossref_primary_10_3389_fpubh_2022_975992 crossref_primary_10_1177_14782715241255977 |
| Cites_doi | 10.1177/1359105307076233 10.1007/s11136-013-0457-y 10.3390/medicina57010043 10.1016/0168-8510(90)90421-9 10.1136/bmjopen-2020-047680 10.1080/21641846.2017.1287546 10.1186/s12955-015-0356-8 10.3390/medicina57030300 10.1016/j.jbi.2019.103208 10.1177/1359104515602373 10.3390/medicina57030200 10.3109/07853890109002087 10.1186/s12967-020-02269-0 10.1097/00004583-200502000-00007 10.1186/1471-2458-11-402 10.1186/s12955-019-1091-3 10.1007/s11136-019-02411-6 10.1111/j.1365-2214.2011.01298.x 10.1371/journal.pone.0132421 10.1016/j.phrs.2021.105465 10.1016/j.jbi.2008.08.010 10.1023/A:1026459027453 10.1186/s12967-020-02534-2 10.1007/978-3-030-47622-9_2 10.1007/978-94-007-7596-1 10.1007/978-3-030-47622-9_4 |
| ContentType | Journal Article |
| Copyright | Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 |
| Copyright_xml | – notice: Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 |
| DBID | 9YT ACMMV AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 88G 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR BTHHO CCPQU COVID DWQXO FYUFA GHDGH GNUQQ K9- K9. KB0 M0R M0S M1P M2M NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM DOA |
| DOI | 10.1136/bmjopen-2021-058128 |
| DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central BMJ Journals ProQuest One Community College Coronavirus Research Database ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database Health & Medical Collection (Alumni Edition) Medical Database Psychology Database Nursing & Allied Health Premium Proquest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Family Health (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition BMJ Journals ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: ACMMV name: BMJ Journals:Open Access url: https://journals.bmj.com/ sourceTypes: Publisher – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 2044-6055 |
| ExternalDocumentID | oai_doaj_org_article_3f08d184dac5475cacf447fbc24271bb PMC9062824 35501074 10_1136_bmjopen_2021_058128 bmjopen |
| Genre | Journal Article |
| GeographicLocations | Canada United Kingdom--UK Australia United States--US |
| GeographicLocations_xml | – name: Canada – name: United Kingdom--UK – name: United States--US – name: Australia |
| GroupedDBID | --- 4.4 53G 5VS 7RV 7X7 7~R 88E 8FI 8FJ 9YT ABUWG ACGFS ACMMV ADBBV AENEX AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BKNYI BPHCQ BTFSW BTHHO CCPQU DIK DWQXO EBS FYUFA GNUQQ GROUPED_DOAJ GX1 H13 HMCUK HYE HZ~ K9- KQ8 M0R M1P M2M M48 M~E NAPCQ O9- OK1 PGMZT PHGZT PIMPY PQQKQ PROAC PSQYO PSYQQ RHI RMJ RPM UKHRP AAYXX ADRAZ BVXVI CITATION EJD PHGZM CGR CUY CVF ECM EIF NPM PJZUB PPXIY 3V. 7XB 8FK COVID K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-b4548-5a0296868ed6afb3f56961beecc795c2b8b7f386f41a2654e8209d6c2d0503773 |
| IEDL.DBID | M48 |
| ISSN | 2044-6055 |
| IngestDate | Wed Aug 27 01:13:43 EDT 2025 Thu Aug 21 14:07:33 EDT 2025 Thu Sep 04 17:10:47 EDT 2025 Sat Jul 26 00:27:36 EDT 2025 Mon Jul 21 06:03:49 EDT 2025 Tue Jul 01 02:44:55 EDT 2025 Thu Apr 24 22:56:42 EDT 2025 Thu Apr 24 22:50:27 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | social medicine neurology public health |
| Language | English |
| License | This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b4548-5a0296868ed6afb3f56961beecc795c2b8b7f386f41a2654e8209d6c2d0503773 |
| Notes | Original research ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-2143-1646 0000-0003-2839-2651 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1136/bmjopen-2021-058128 |
| PMID | 35501074 |
| PQID | 2666488347 |
| PQPubID | 2040975 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_3f08d184dac5475cacf447fbc24271bb pubmedcentral_primary_oai_pubmedcentral_nih_gov_9062824 proquest_miscellaneous_2659228939 proquest_journals_2666488347 pubmed_primary_35501074 crossref_citationtrail_10_1136_bmjopen_2021_058128 crossref_primary_10_1136_bmjopen_2021_058128 bmj_journals_10_1136_bmjopen_2021_058128 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-05-02 |
| PublicationDateYYYYMMDD | 2022-05-02 |
| PublicationDate_xml | – month: 05 year: 2022 text: 2022-05-02 day: 02 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London – name: BMA House, Tavistock Square, London, WC1H 9JR |
| PublicationSeriesTitle | Original research |
| PublicationTitle | BMJ open |
| PublicationTitleAbbrev | BMJ Open |
| PublicationTitleAlternate | BMJ Open |
| PublicationYear | 2022 |
| Publisher | British Medical Journal Publishing Group BMJ Publishing Group LTD BMJ Publishing Group |
| Publisher_xml | – name: British Medical Journal Publishing Group – name: BMJ Publishing Group LTD – name: BMJ Publishing Group |
| References | Falk Hvidberg, Brinth, Olesen (R2) 2015; 10 Njoku, Jason, Torres-Harding (R7) 2007; 12 Brittain, Muirhead, Finlay (R4) 2021; 57 Velleman, Collin, Beasant (R27) 2016; 21 Rangel, Garralda, Jeffs (R29) 2005; 44 Jonsjö, Wicksell, Holmström (R26) 2017; 5 Lim, Ahn, Jang (R6) 2020; 18 Friedman, Murovska, Pheby (R8) 2021; 57 Harris, Taylor, Thielke (R12) 2009; 42 Nacul, Lacerda, Campion (R24) 2011; 11 Harris, Taylor, Minor (R11) 2019; 95 (R13) 1990; 16 Shah, Ali, Nixon (R19) 2021; 11 Feng, Devlin, Herdman (R21) 2015; 13 Rabin, de Charro (R9) 2001; 33 Missen, Hollingworth, Eaton (R28) 2012; 38 Toogood, Clauw, Phadke (R5) 2021; 165 Chantarasap, Johns, Pairojkul (R18) 2019; 17 Brenna, Araja, Pheby (R25) 2021; 57 Myers, Wilks (R23) 1999; 8 Golics, Basra, Finlay (R10) 2014; 23 Eaton-Fitch, Johnston, Zalewski (R1) 2020; 29 2022051703285397000_12.5.e058128.24 2022051703285397000_12.5.e058128.27 2022051703285397000_12.5.e058128.28 2022051703285397000_12.5.e058128.29 2022051703285397000_12.5.e058128.20 2022051703285397000_12.5.e058128.21 2022051703285397000_12.5.e058128.22 Toogood (2022051703285397000_12.5.e058128.5) 2021; 165 2022051703285397000_12.5.e058128.23 Jonsjö (2022051703285397000_12.5.e058128.26) 2017; 5 2022051703285397000_12.5.e058128.7 Brenna (2022051703285397000_12.5.e058128.25) 2021; 57 2022051703285397000_12.5.e058128.6 2022051703285397000_12.5.e058128.9 2022051703285397000_12.5.e058128.3 Friedman (2022051703285397000_12.5.e058128.8) 2021; 57 2022051703285397000_12.5.e058128.13 2022051703285397000_12.5.e058128.2 2022051703285397000_12.5.e058128.14 2022051703285397000_12.5.e058128.15 2022051703285397000_12.5.e058128.16 2022051703285397000_12.5.e058128.17 2022051703285397000_12.5.e058128.19 Chantarasap (2022051703285397000_12.5.e058128.18) 2019; 17 Brittain (2022051703285397000_12.5.e058128.4) 2021; 57 2022051703285397000_12.5.e058128.10 2022051703285397000_12.5.e058128.11 2022051703285397000_12.5.e058128.12 Eaton-Fitch (2022051703285397000_12.5.e058128.1) 2020; 29 |
| References_xml | – volume: 12 start-page: 461 year: 2007 ident: R7 article-title: The prevalence of chronic fatigue syndrome in Nigeria publication-title: J Health Psychol doi: 10.1177/1359105307076233 – volume: 23 start-page: 317 year: 2014 ident: R10 article-title: The development and validation of the Family Reported Outcome Measure (FROM-16)© to assess the impact of disease on the partner or family member publication-title: Qual Life Res doi: 10.1007/s11136-013-0457-y – volume: 57 year: 2021 ident: R4 article-title: Myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS): major impact on lives of both patients and family members publication-title: Medicina doi: 10.3390/medicina57010043 – volume: 16 start-page: 199 year: 1990 ident: R13 article-title: EuroQol--a new facility for the measurement of health-related quality of life publication-title: Health Policy doi: 10.1016/0168-8510(90)90421-9 – volume: 11 year: 2021 ident: R19 article-title: Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey publication-title: BMJ Open doi: 10.1136/bmjopen-2020-047680 – volume: 5 start-page: 33 year: 2017 ident: R26 article-title: Identifying symptom subgroups in patients with ME/CFS – relationships to functioning and quality of life publication-title: Fatigue: Biomedicine, Health & Behavior doi: 10.1080/21641846.2017.1287546 – volume: 13 start-page: 171 year: 2015 ident: R21 article-title: Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare? publication-title: Health Qual Life Outcomes doi: 10.1186/s12955-015-0356-8 – volume: 57 year: 2021 ident: R25 article-title: Comparative survey of people with ME/CFS in Italy, Latvia, and the UK: a report on behalf of the socioeconomics Working group of the European ME/CFS research network (EUROMENE) publication-title: Medicina doi: 10.3390/medicina57030300 – volume: 95 year: 2019 ident: R11 article-title: The REDCap Consortium: building an international community of software platform partners publication-title: J Biomed Inform doi: 10.1016/j.jbi.2019.103208 – volume: 21 start-page: 618 year: 2016 ident: R27 article-title: Psychological wellbeing and quality-of-life among siblings of paediatric CFS/ME patients: a mixed-methods study publication-title: Clin Child Psychol Psychiatry doi: 10.1177/1359104515602373 – volume: 57 year: 2021 ident: R8 article-title: Our evolving understanding of ME/CFS publication-title: Medicina doi: 10.3390/medicina57030200 – volume: 33 start-page: 337 year: 2001 ident: R9 article-title: EQ-5D: a measure of health status from the EuroQol group publication-title: Ann Med doi: 10.3109/07853890109002087 – volume: 18 start-page: 1 year: 2020 ident: R6 article-title: Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) publication-title: J Transl Med doi: 10.1186/s12967-020-02269-0 – volume: 44 start-page: 150 year: 2005 ident: R29 article-title: Family health and characteristics in chronic fatigue syndrome, juvenile rheumatoid arthritis, and emotional disorders of childhood publication-title: J Am Acad Child Adolesc Psychiatry doi: 10.1097/00004583-200502000-00007 – volume: 11 year: 2011 ident: R24 article-title: The functional status and well being of people with myalgic Encephalomyelitis/Chronic fatigue syndrome and their carers publication-title: BMC Public Health doi: 10.1186/1471-2458-11-402 – volume: 17 year: 2019 ident: R18 article-title: Validation of the Thai version of the family reported outcome measure (FROM-16)© to assess the impact of disease on the partner or family members of patients with cancer publication-title: Health Qual Life Outcomes doi: 10.1186/s12955-019-1091-3 – volume: 29 start-page: 1521 year: 2020 ident: R1 article-title: Health-Related quality of life in patients with myalgic Encephalomyelitis/Chronic fatigue syndrome: an Australian cross-sectional study publication-title: Qual Life Res doi: 10.1007/s11136-019-02411-6 – volume: 38 start-page: 505 year: 2012 ident: R28 article-title: The financial and psychological impacts on mothers of children with chronic fatigue syndrome (CFS/ME) publication-title: Child Care Health Dev doi: 10.1111/j.1365-2214.2011.01298.x – volume: 10 year: 2015 ident: R2 article-title: The health-related quality of life for patients with myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) publication-title: PLoS One doi: 10.1371/journal.pone.0132421 – volume: 165 start-page: 105465 year: 2021 ident: R5 article-title: Myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS): where will the drugs come from? publication-title: Pharmacol Res doi: 10.1016/j.phrs.2021.105465 – volume: 42 start-page: 377 year: 2009 ident: R12 article-title: Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support publication-title: J Biomed Inform doi: 10.1016/j.jbi.2008.08.010 – volume: 8 start-page: 9 year: 1999 ident: R23 article-title: Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome publication-title: Qual Life Res doi: 10.1023/A:1026459027453 – ident: 2022051703285397000_12.5.e058128.13 doi: 10.1016/0168-8510(90)90421-9 – ident: 2022051703285397000_12.5.e058128.3 – volume: 57 year: 2021 ident: 2022051703285397000_12.5.e058128.25 article-title: Comparative survey of people with ME/CFS in Italy, Latvia, and the UK: a report on behalf of the socioeconomics Working group of the European ME/CFS research network (EUROMENE) publication-title: Medicina doi: 10.3390/medicina57030300 – ident: 2022051703285397000_12.5.e058128.29 doi: 10.1097/00004583-200502000-00007 – volume: 17 year: 2019 ident: 2022051703285397000_12.5.e058128.18 article-title: Validation of the Thai version of the family reported outcome measure (FROM-16)© to assess the impact of disease on the partner or family members of patients with cancer publication-title: Health Qual Life Outcomes doi: 10.1186/s12955-019-1091-3 – ident: 2022051703285397000_12.5.e058128.12 doi: 10.1016/j.jbi.2008.08.010 – ident: 2022051703285397000_12.5.e058128.11 doi: 10.1016/j.jbi.2019.103208 – ident: 2022051703285397000_12.5.e058128.2 doi: 10.1371/journal.pone.0132421 – ident: 2022051703285397000_12.5.e058128.6 doi: 10.1186/s12967-020-02534-2 – ident: 2022051703285397000_12.5.e058128.16 – ident: 2022051703285397000_12.5.e058128.14 doi: 10.1007/978-3-030-47622-9_2 – volume: 5 start-page: 33 year: 2017 ident: 2022051703285397000_12.5.e058128.26 article-title: Identifying symptom subgroups in patients with ME/CFS – relationships to functioning and quality of life publication-title: Fatigue: Biomedicine, Health & Behavior – volume: 29 start-page: 1521 year: 2020 ident: 2022051703285397000_12.5.e058128.1 article-title: Health-Related quality of life in patients with myalgic Encephalomyelitis/Chronic fatigue syndrome: an Australian cross-sectional study publication-title: Qual Life Res doi: 10.1007/s11136-019-02411-6 – ident: 2022051703285397000_12.5.e058128.7 doi: 10.1177/1359105307076233 – ident: 2022051703285397000_12.5.e058128.21 doi: 10.1186/s12955-015-0356-8 – ident: 2022051703285397000_12.5.e058128.27 doi: 10.1177/1359104515602373 – ident: 2022051703285397000_12.5.e058128.28 doi: 10.1111/j.1365-2214.2011.01298.x – ident: 2022051703285397000_12.5.e058128.23 doi: 10.1023/A:1026459027453 – ident: 2022051703285397000_12.5.e058128.17 doi: 10.1007/978-94-007-7596-1 – volume: 57 year: 2021 ident: 2022051703285397000_12.5.e058128.8 article-title: Our evolving understanding of ME/CFS publication-title: Medicina doi: 10.3390/medicina57030200 – ident: 2022051703285397000_12.5.e058128.19 doi: 10.1136/bmjopen-2020-047680 – ident: 2022051703285397000_12.5.e058128.22 – volume: 57 year: 2021 ident: 2022051703285397000_12.5.e058128.4 article-title: Myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS): major impact on lives of both patients and family members publication-title: Medicina doi: 10.3390/medicina57010043 – volume: 165 start-page: 105465 year: 2021 ident: 2022051703285397000_12.5.e058128.5 article-title: Myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS): where will the drugs come from? publication-title: Pharmacol Res doi: 10.1016/j.phrs.2021.105465 – ident: 2022051703285397000_12.5.e058128.20 – ident: 2022051703285397000_12.5.e058128.9 doi: 10.3109/07853890109002087 – ident: 2022051703285397000_12.5.e058128.15 doi: 10.1007/978-3-030-47622-9_4 – ident: 2022051703285397000_12.5.e058128.24 doi: 10.1186/1471-2458-11-402 – ident: 2022051703285397000_12.5.e058128.10 doi: 10.1007/s11136-013-0457-y |
| SSID | ssj0000459552 |
| Score | 2.3409321 |
| Snippet | ObjectivesThe aim of this study was to assess the impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life (QoL) of people... The aim of this study was to assess the impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life (QoL) of people with... Objectives The aim of this study was to assess the impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life (QoL) of people... |
| SourceID | doaj pubmedcentral proquest pubmed crossref bmj |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e058128 |
| SubjectTerms | Adolescent Adult Aged Aged, 80 and over Chronic fatigue syndrome Consent COVID-19 Cross-Sectional Studies Demographics Disease Encephalomyelitis Family Fatigue Syndrome, Chronic - psychology Female Humans Male Middle Aged Neurology Patients public health Quality of Life Questionnaires social medicine Statistical analysis Surveys and Questionnaires Young Adult |
| SummonAdditionalLinks | – databaseName: BMJ Open Access Journals dbid: 9YT link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9RAEF9qhVIQ0ao1WmUFHyqYXrLf8U2lpQr1xRbqU9hNNm3lLjnuQ7h_zb_Omd3k9ESKT4HNZsnuzM7OzM78hpDXLDMeEzjTqhFgoBQ5T0GpN2nFQWQabWxeY77z2Rd1eiE-X8rLLZIPuTBu8h3LRh3BM2Y0IEZTuxjlbCRHPpNwHpkj9EzfIXexNkkoWvDtfO1WAQ2lkKHODsuESEFZlz3WUM7VMDqwBgMjOgy2S3bgyM0wLhGOF-iwcUAFHP9_KZ9_x1D-cSidPCD3e22Svo_kf0i2fLtHds76-_I9ci965WhMNnpEfn4KSZG0a-hkZccg9Sju7Om1HXeTlcdQuPmoini5tAGiXS09HUAN6OHZMWySr29o11LQG2lMyFzhaOObxuMzBqRT9O7S2JvatqbhOoJOgU1bUDdDU_Ss0InHiiTzd9BGI2oHDeuSzkOMGM5uvpz98KvH5OLk-PzjadpXb0idADMolTZjhTLK-FrZxvFGqkLlzgPP6EJWzBmnG24U8IhlSgoPukhRq4rVCFGjNX9Cttuu9U8J5dZaI5xGqBnBtDe5NiCnuGkKVzQVT8ghEK7sd9-8DIYNV2VP7hLJXUZyJ4QN1C2rHgUdi3GMb__o7fqjaQQBub37B2SbdVdE8A4N3eyq7AVCyZvM1GBe17aSQsvKwmYRunEVzjB3LiEHA9P9nhhoUwokLhc6Ia_Wr0Eg4C2PbX23xD6yYGBG8yIh-5FH138ycHpC9Ab3bvzq5pv25jqAjiOetWHi2f8v9XOyyzBXBKND2QHZXsyW_gVocAv3MuzZX-r8P6M priority: 102 providerName: BMJ Publishing Group Ltd – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2gICNxKBLRJnb84gaoVUFaLlCpt8hObNpqN1k1XaT9a_11nbGzyy5C5cIpkuNEtufhGXvmG0LeskJ7TODMm1CBg2JKnoNRr_OGg8rUStuyxXzn6Td5fFJ9PRWnW6W-MCYswQOnhZvwUOgW3JDWNqJSorHw00oF18DeokrnUPsWpthypqIOroQRgo0wQyWXEze_wHpUwBUM_GcB-xpmpEDrzoYUcfv_Zmz-GTO5tQkdPSD3R-uRfkyjfkju-O4RuTsd78cfk-svMemR9oHOV3YGWo2i5C7O7KyfrzyGug2TJuHh0gBE-bn0dA1aQA-mhyAE39_RvqNgF9KUcLnCv83Og8dnCjineHpLU29qu5bG6wa6gNXswJyMTenkhM49VhwZPkAbTagcNK5DPsQYMJzNsLz85VdPyMnR4Y_Px_lYnSF3Fbg5ubAFM1JL7Vtpg-NBSCNL54EnlBENc9qpwLUEHrBMisqDrWFa2bAWIWiU4k_JXtd3_jmh3FqrK6cQSgao6nWpNOghroNxJjQ8IwdAqHqUrqGOjguX9UjTGmlaJ5pmhK2pWTcjyjkW25jd_tH7zUeLBPJxe_dPyCabrojQHRuAb-uRb-t_8W1G9tdM9ntiYC1J0Ki8Uhl5s3kNAo-3OLbz_RL7CMPATeYmI88ST25GAsZjgRG2GVE73Loz1N033flZBBVHvGrNqhf_Y24vyT2GWSIYF8r2yd7V5dK_Atvtyr2OYnoD_oBC3Q priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1taxQxEA61BfGL-N7VKhH8UMGlt8nmZQURK1eqcIeohX5bkmzSVu52z7uecH_NX-dMdvfqidyng2z2SHaeTGaSmWcIecUG2mMCZ-pCDg5KkfEUjHqdOg4qUyttsgrznUdjeXqWfz4X5ztk3OfCYFhlrxOjoq4ah2fkR7CRSAAbz9X72c8Uq0bh7WpfQsN0pRWqd5Fi7BbZA5WsAfd7x8Pxl6_rUxcwYAohWEc_lHF5ZKc_sE4VoIWBXy1gv8NMFWjd2Kgin___jNB_Yyn_2pxO7pG7nVVJP7QwuE92fP2A3B519-YPye9PMRmSNoFOV2YC2o7iip5dmkkzXXkMgVscuZYnlwYQ1sXS057MgB6OhrA4vr2mTU3BXqRtIuYK_21yFTz-toHoFE91adubmrqi8RqCzgCeNZiZsak9UaFTj5VIFm-hjbZsHTR-h3QRY8NwNovl_JdfPSJnJ8PvH0_TrmpDanNwf1JhBqyQWmpfSRMsD0IWMrMesKIK4ZjVVgWuJWDDMClyDzZIUUnHKqSmUYo_Jrt1U_t9QrkxRudWIcVMzpTXmdKgn7gOhS2C4wk5BEGV3apblNGh4bLsZFqiTMtWpglhvTRL17GfYxGOyfaX3qxfmrXkH9u7HyNM1l2RuTs2NPOLslMEJQ8DXYFbXRknciWcgUWSq2AdzjCzNiEHPchuJnYD_oS8XD8GRYC3O6b2zRL7iIKB-8yLhDxpMbkeCRiVA4y8TYjaQOvGUDef1FeXkWwceaw1y59uH9YzcodhXghGgrIDsns9X_rnYK1d2xfdEvwDD4BAQA priority: 102 providerName: ProQuest |
| Title | Impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life of people with ME/CFS and their partners and family members: an online cross-sectional survey |
| URI | https://bmjopen.bmj.com/content/12/5/e058128.full https://www.ncbi.nlm.nih.gov/pubmed/35501074 https://www.proquest.com/docview/2666488347 https://www.proquest.com/docview/2659228939 https://pubmed.ncbi.nlm.nih.gov/PMC9062824 https://doaj.org/article/3f08d184dac5475cacf447fbc24271bb |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZ2kaa9IO4LjMpIPAyJsMaOL0FCaJs6BlInBCsqT5GdONtQm5R2RfSv8es4x0kKRWMPvCSSL5Gdc3wu9vF3CHnGutrhBc4wK2JwUJKIh2DU6zDjIDK10ibK8b5z_1SeDOL3QzFcI21W1OYHzq517TCf1GA6evnj2-INLPjXTUaSfTv-ilVAcAausQCVpdfJJqgmid5Yv7H3vWiORSIEa9CH_tF3m2yBEu5ipCIoHGiworI8sv915ujfUZV_qKnj2-RWY1_Sg5oh7pA1V94lW_3mBP0e-fnOX4ukVUHHCzMCuUdxbU8uzKgaLxwGw832sxoxlxZAtvO5oy2sAd3r92CZfHpOq5KC5UjrK5kL_NrosnD4rkPSKe7v0ro1NWVO_YEEnQCjlmBw-qJ6b4WOHeYkmb2CMlrjdlD_H8KZjxLD2czm0-9ucZ8MjntnRydhk78htDE4QqEwXZZILbXLpSksL4RMZGQdcI1KRMastqrgWgKXGCZF7MAaSXKZsRxBapTiD8hGWZVuh1BujNGxVQg2EzPldKQ0SCqui8QmRcYDsgeESlv2Sb1rw2XakDdF8qY1eQPCWmqmWYODjuk4Rjd3erHsNKlhQG5ufohssmyKGN6-oJqep41ISHnR1Tk42LnJRKxEZmC5xKqwGc4wsjYguy2T_Z4Y2FMSZC6PVUCeLqtBJOA5jyldNcc2ImHgSPMkIA9rnlyOpOXsgKgVbl0Z6mpNeXnhYccR0Vqz-NF_93xMthleHsFwUbZLNq6mc_cETLor2yHraqjgmXw565DNg6N-_zO8D3unHz52_DYJPN8Oo45fzr8AvEhSiw |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwEviG8CA4wE0pCI2tiJ7SBNiEGnlq0Vgk3aW2YnzjbUJqVZQfnXeOBv4y4fHUWob3uq5DiRr_fhO_vud4S8ZD1lsYDTjVMfApTQ4y449cqNOZhMJZX2Eqx3Ho3F4Mj_dBwcb5DfbS0MplW2NrEy1Eke4xl5FzYSAcLGfflu9t3FrlF4u9q20NBNa4Vkp4IYawo79m35E0K4Ymf4Efj9irG9_uGHgdt0GXCND-66G-geC4USyiZCp4angQiFZyzQJsMgZkYZmXIlgBbNROBb2DPDRMQsQSgVKTl89xrZ9LHCtUM2d_vjz1-WpzzgMIVBwBq4I4-Lrpl-w75YIJ0M4vgA9lesjIHRlY2x6h_wP6f339zNvzbDvdvkVuPF0ve12N0hGza7S66Pmnv6e-TXsCq-pHlKp6WegHWlaEFmZ3qST0uLKXdFN65xeWkKwnG6sLQFT6Dboz4o49fXNM8o-Ke0Lvws8WuT89Tib534TvEUmdazqc4SWl170BmoQwZubTVUn-DQqcXOJ8VbGKM1Ogit_ge3qHLRkJpiMf9hy_vk6Er494B0sjyzjwjlWmvlG4mQNj6TVnlSgT3kKg1NmMbcIdvAqKjR8iKqAiguooanEfI0qnnqENZyM4obtHVs-jFZ_9Kb5UuzGmxk_fRdFJPlVEQKrwby-WnUGJ6Ipz2VQBif6DjwZRBrUEpfpiZGCj1jHLLVCtklYZfK5pAXy8dgePA2SWc2X-CcIGQQrvPQIQ9rmVyuBJzYHmb6OkSuSOvKUlefZOdnFbg54mYr5j9ev6zn5MbgcHQQHQzH-0_ITYY1KZiFyrZI52K-sE_BU7wwzxp1pOTkqi3AH-9We-s |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkCZeEN8EBhgJpCERtbET20FCCNiqldEJCSb1LdiJvQ21SWlWUP-1_XXcOUlHEdrbnio5TuTrffjOvvsdIS9YX1ks4AxzF0OAkkY8BKdehTkHk6mk0lGB9c6jQ7F_FH8aJ-MNct7VwmBaZWcTvaEuqhzPyHuwkQgQNh7LnmvTIr7sDt7NfobYQQpvWrt2Go2IHNjlbwjf6rfDXeD1S8YGe98-7odth4HQxOCqh4nus1QooWwhtDPcJSIVkbFAl0yTnBllpONKAB2aiSS2sF-mhchZgTAqUnL47jVyXXLwqkCX5FiuznfAVUqThLVARxEXPTP9gR2xQC4ZRPAJ7KxYEwOja1ui7xzwP3f336zNv7bBwS1ys_Vf6ftG4G6TDVveIVuj9ob-Ljkf-rJLWjk6XeoJ2FWKtmN2oifVdGkx2a7u5Q0iL3UgFscLSzvYBLoz2gM1_PqKViUFz5Q2JZ9L_Nrk1Fn8bVLeKZ4f02Y21WVB_YUHnYEilODQ-qHm7IZOLfY8qd_AGG1wQaj_H8LaZ6EhNfVi_ssu75GjK-HefbJZVqV9SCjXWqvYSASziZm0KpIKLCFXLjWpy3lAdoBRWavfdeZDJy6ylqcZ8jRreBoQ1nEzy1ucdWz3Mbn8pderl2YNzMjl0z-gmKymIka4H6jmx1lrcjLu-qqAAL7QeRLLJNegjrF0JkcKI2MCst0J2QVhF2oWkOerx2By8B5Jl7Za4JwkZRCo8zQgDxqZXK0E3Nc-5vgGRK5J69pS15-Upyce1hwRsxWLH12-rGdkC_Q--zw8PHhMbjAsRsH0U7ZNNs_mC_sEXMQz89TrIiXfr1r5_wB_SHmB |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+myalgic+encephalomyelitis%2Fchronic+fatigue+syndrome+%28ME%2FCFS%29+on+the+quality+of+life+of+people+with+ME%2FCFS+and+their+partners+and+family+members%3A+an+online+cross-sectional+survey&rft.jtitle=BMJ+open&rft.au=Vyas%2C+Jui&rft.au=Muirhead%2C+Nina&rft.au=Singh%2C+Ravinder&rft.au=Ephgrave%2C+Rachel&rft.series=Original+research&rft.date=2022-05-02&rft.pub=BMJ+Publishing+Group&rft.eissn=2044-6055&rft.volume=12&rft.issue=5&rft_id=info:doi/10.1136%2Fbmjopen-2021-058128&rft_id=info%3Apmid%2F35501074&rft.externalDocID=PMC9062824 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2044-6055&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2044-6055&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2044-6055&client=summon |